Pfizer Overpays for Seagen, but Who's Counting

Date:



Buying prime biotech property as different huge pharmaceutical firms face a patent cliff was sure to be costly.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Job Listings Abound, but Many Are Fake

A thriller permeates the job market: You apply...

Online Casino Free Credit

On-line on line casino free credit score is...

Julia Fox SLAMS Rumor She’s Using Ozempic To Lose Weight: ‘I Would Never Do That’

Julia Fox doesn’t maintain again. That’s what we...